Search / Trial NCT00000582

Cooperative Study of Factor VIII Inhibitors

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Oct 27, 1999

Trial Information

Current as of December 05, 2024

Completed

Keywords

ClinConnect Summary

BACKGROUND:

Despite major advances in the treatment of patients with hemophilia, a serious remaining challenge was presented by the occurrence of circulating inhibitors to Factor VIII. Because of lack of information on the natural course of patients with Factor VIII inhibitors, the relative efficacy of various modes of therapy was not established. The Division of Blood Diseases and Resources decided to sponsor a clinical investigation which would evaluate populations of hemophilia patients for Factor VIII inhibitors, follow up these patients to provide information on the natural history of...

Gender

MALE

Eligibility criteria

  • Males with hemophilia, not stratified as to ethnic group.

Trial Officials

Louis Aledort

Icahn School of Medicine at Mount Sinai

J. Edson

University of Minnesota

M. Eyster

Milton S. Hershey Medical Center

Scott Goodnight

University of Oregon Health Sciences Center

William Hathaway

University of Colorado Medical Center

Jack Lazerson

Milwaukee Children's Hospital

Peter Levine

Memorial hospital

Jeanne Lusher

Wayne State University

Campbell McMillan

University of North Carolina

Sandor Shapiro

Thomas Jefferson University

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials